SlideShare une entreprise Scribd logo
1  sur  16
Non linear pharmacokinetics
PHARMACOKINETICS
The study of absorption, distibution,metabolism,excretio of drug
and their relationship to pharmacological response. In simple
word ; what the body dose to the drug. Linear
pharmacokinetics.In the pharmacokinetic parameter for drug
would not change when difference dose or multiple dose of drug
is given. Non linear pharmcokinetics-if any deviation cause linear
pharmacokinetics called non linear, mixed, capacity – limited
kinetics.
CAUSES Of NON LINEARITY
 Absorption
 Saturable transport - riboflavin
 Intestinal metabolism - prodrug
 Distribution
 Plasma protein binding - cefriaxone
 CSF transport – benzyl penicillin
 Tissue binding - prednisolone
 Cellular Uptake - methicillin
 Hepatic uptake – indocyanin green
 Metabolism
 Saturable metabolism – phynetoin
 Co-substrate depletion – acetaminophen
 plasma protein binding – prednisolone
 Elimination
 Glomerular filtration -
 Tubular secretion – penicilline G
 Tubular reabsorption – water soluble vitamin
AUC
DOSE
MICHAELIS-MENTEN KINETICS
Drug biotransformation ,renal tubular secretion,and biliary
secretion usually require enzyme or carrier systems. These
systems are relatively specific with respect to substrate and have
finite capacities(I.e., they are said to be capacity limited).
Frequently, the kinetics of these capacity-limited processes can be
described by the Michaelis Menten equation:
dc/dt – rate of decline of drug concentration with time .
Vmax - theoretical maximum rate of the process.
Km – michelis constant
C<<Km – under this stiuation ,the equation Km+C =km
-dC/dt=Vmax C/ Km
C>>Km- under this situation Km+C=C
-dC/dt=Vmax
-dC/dt
Km Concentration
Vmax
ESTIMATION OF Km AND Vmax
 The parameter of capacity limited processes like metabolism,
renal tubular secretion and excretion can be easily define by
assuming one compartment kinetics for the drug and that
elimination invovles only a single capacity limited process.
 The Km and Vmax can be assessed from the plasma conc .time data
collected after i.v bolus administration of drug with non linear
elimination.
 Rewritting equation –
dc/dt =Vmax c/Km+c
 Integration followed by conversation to log10
log C=logC0 + (c0 -c)/2.303Km –Vmax / 2.303Km
 The Equation describe the line-
LogC=logC<-
0 –Vmax /2.303Km
At low plasma concentrations are identical. By setting the right-hand
sides of these two equations equal to each other, the following
expression is obtained.
Km AND Vmax FROM STEADY STATE
1) Linear-Burke plot/klotz plot
1/DR= Km/Vmax.Css+1/Vmax
2) The third Graphical method oR Direct Linear Method:
DR= Vmax-Km/Css
100
200
300
400
500
600
700
020406080 20 40
Dmax
KmCss
Dose
Km and Vmax can also be calculated numerically by setting up
simultaneous equation as shown below:
DR= V max Css.1/Km+Css.1
DR= V max Css.2/ Km+Css.2
Combination of the above two equation yields:
Km= DR2-DR1/(DR.1/Css.1)-(DR.2/Css.2)
Non linear pharmacokinetics.

Contenu connexe

Tendances

Non linear pharmacokinetics and different volumes of distribution
Non linear pharmacokinetics and different volumes of distributionNon linear pharmacokinetics and different volumes of distribution
Non linear pharmacokinetics and different volumes of distribution
Malla Reddy College of Pharmacy
 
Urinaryexcreation studies
Urinaryexcreation studiesUrinaryexcreation studies
Urinaryexcreation studies
Sonam Gandhi
 
A seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationA seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administration
Malla Reddy College of Pharmacy
 
Methods of Assessing Bioavailability
Methods of Assessing BioavailabilityMethods of Assessing Bioavailability
Methods of Assessing Bioavailability
Dibrugarh University
 

Tendances (20)

In-Vivo In-Vitro Correlation
In-Vivo In-Vitro CorrelationIn-Vivo In-Vitro Correlation
In-Vivo In-Vitro Correlation
 
Non linear Pharmacokinetics
Non linear PharmacokineticsNon linear Pharmacokinetics
Non linear Pharmacokinetics
 
one compartment model ppt
one compartment model pptone compartment model ppt
one compartment model ppt
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
 
Causes of non linearity in pharmacokinetics pdf
Causes of non linearity in pharmacokinetics pdfCauses of non linearity in pharmacokinetics pdf
Causes of non linearity in pharmacokinetics pdf
 
Pharmacokinetic models
Pharmacokinetic  modelsPharmacokinetic  models
Pharmacokinetic models
 
Non linear pharmacokinetics and different volumes of distribution
Non linear pharmacokinetics and different volumes of distributionNon linear pharmacokinetics and different volumes of distribution
Non linear pharmacokinetics and different volumes of distribution
 
pH partition theory of drug absorption
pH partition theory of drug absorptionpH partition theory of drug absorption
pH partition theory of drug absorption
 
One compartment model intro
One compartment model introOne compartment model intro
One compartment model intro
 
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELSPHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
 
Compartment Modelling
Compartment ModellingCompartment Modelling
Compartment Modelling
 
IN-VITRO-IN VIVO CORRELATION (IVIVC).pptx
IN-VITRO-IN VIVO CORRELATION (IVIVC).pptxIN-VITRO-IN VIVO CORRELATION (IVIVC).pptx
IN-VITRO-IN VIVO CORRELATION (IVIVC).pptx
 
Urinaryexcreation studies
Urinaryexcreation studiesUrinaryexcreation studies
Urinaryexcreation studies
 
Targeted Drug Delivery Systems
Targeted Drug Delivery SystemsTargeted Drug Delivery Systems
Targeted Drug Delivery Systems
 
Michaelis menten kinetics Nonlinear Pharmacokinetics
Michaelis menten kinetics Nonlinear PharmacokineticsMichaelis menten kinetics Nonlinear Pharmacokinetics
Michaelis menten kinetics Nonlinear Pharmacokinetics
 
Biopharmaceutics
BiopharmaceuticsBiopharmaceutics
Biopharmaceutics
 
A seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationA seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administration
 
BIOPHARMACEUTICS OF ANTISENSE MOLECULE AND APTAMERS
BIOPHARMACEUTICS  OF  ANTISENSE MOLECULE AND  APTAMERSBIOPHARMACEUTICS  OF  ANTISENSE MOLECULE AND  APTAMERS
BIOPHARMACEUTICS OF ANTISENSE MOLECULE AND APTAMERS
 
Methods of Assessing Bioavailability
Methods of Assessing BioavailabilityMethods of Assessing Bioavailability
Methods of Assessing Bioavailability
 
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
 

Similaire à Non linear pharmacokinetics.

Michaelis-menten kinetics
Michaelis-menten kineticsMichaelis-menten kinetics
Michaelis-menten kinetics
Munawar Ali
 
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciencesTherapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
khalafpharm
 
The aim of the use of meloxicam in patients with mild or mo
The aim of  the use of meloxicam in patients with mild or moThe aim of  the use of meloxicam in patients with mild or mo
The aim of the use of meloxicam in patients with mild or mo
MUSHTAQ AHMED
 
7 29-10enzymeskinetics-coloso-110715062024-phpapp01[1]
7 29-10enzymeskinetics-coloso-110715062024-phpapp01[1]7 29-10enzymeskinetics-coloso-110715062024-phpapp01[1]
7 29-10enzymeskinetics-coloso-110715062024-phpapp01[1]
Khamees Faraj
 

Similaire à Non linear pharmacokinetics. (20)

NONLINEAR PHARMACOKINETICS_ppt.pdf
NONLINEAR PHARMACOKINETICS_ppt.pdfNONLINEAR PHARMACOKINETICS_ppt.pdf
NONLINEAR PHARMACOKINETICS_ppt.pdf
 
Concept of nonlinear pharmacokinetic
Concept of nonlinear pharmacokineticConcept of nonlinear pharmacokinetic
Concept of nonlinear pharmacokinetic
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
 
Michaelis-menten kinetics
Michaelis-menten kineticsMichaelis-menten kinetics
Michaelis-menten kinetics
 
Non linear pharmacokinetics
Non linear pharmacokineticsNon linear pharmacokinetics
Non linear pharmacokinetics
 
Biopharmaceutics Non linear pharmacokinetics
Biopharmaceutics Non linear pharmacokineticsBiopharmaceutics Non linear pharmacokinetics
Biopharmaceutics Non linear pharmacokinetics
 
Nonlinear pharmacokinetic
Nonlinear pharmacokineticNonlinear pharmacokinetic
Nonlinear pharmacokinetic
 
Non linear Pharmacokinetics 2
Non linear Pharmacokinetics 2Non linear Pharmacokinetics 2
Non linear Pharmacokinetics 2
 
BPharma-6Sem-Biopharmaceutics & Pharmacokinetics.pdf
BPharma-6Sem-Biopharmaceutics & Pharmacokinetics.pdfBPharma-6Sem-Biopharmaceutics & Pharmacokinetics.pdf
BPharma-6Sem-Biopharmaceutics & Pharmacokinetics.pdf
 
NONLINEAR PHARMACOKINETICS
NONLINEAR PHARMACOKINETICSNONLINEAR PHARMACOKINETICS
NONLINEAR PHARMACOKINETICS
 
Abp08.pptx
Abp08.pptxAbp08.pptx
Abp08.pptx
 
Mechanism of absorption
Mechanism of absorptionMechanism of absorption
Mechanism of absorption
 
non linear pharmacokinetics
 non linear pharmacokinetics non linear pharmacokinetics
non linear pharmacokinetics
 
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciencesTherapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
 
Basics of Pharmacokinetics
Basics of PharmacokineticsBasics of Pharmacokinetics
Basics of Pharmacokinetics
 
Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens
 
The aim of the use of meloxicam in patients with mild or mo
The aim of  the use of meloxicam in patients with mild or moThe aim of  the use of meloxicam in patients with mild or mo
The aim of the use of meloxicam in patients with mild or mo
 
Kinetika En 2002
Kinetika En 2002Kinetika En 2002
Kinetika En 2002
 
Kinetika En 2002
Kinetika En 2002Kinetika En 2002
Kinetika En 2002
 
7 29-10enzymeskinetics-coloso-110715062024-phpapp01[1]
7 29-10enzymeskinetics-coloso-110715062024-phpapp01[1]7 29-10enzymeskinetics-coloso-110715062024-phpapp01[1]
7 29-10enzymeskinetics-coloso-110715062024-phpapp01[1]
 

Plus de jatin singla

regulation of herbal products
regulation of herbal productsregulation of herbal products
regulation of herbal products
jatin singla
 
Jatin an overview of sunscreen regulations in the world
Jatin  an overview of sunscreen regulations in the worldJatin  an overview of sunscreen regulations in the world
Jatin an overview of sunscreen regulations in the world
jatin singla
 

Plus de jatin singla (20)

Jatin singla
Jatin singlaJatin singla
Jatin singla
 
Jatin singla
Jatin singlaJatin singla
Jatin singla
 
Jatin singla
Jatin singlaJatin singla
Jatin singla
 
Jatin singla
Jatin singlaJatin singla
Jatin singla
 
Jatin singla
Jatin singlaJatin singla
Jatin singla
 
Jatin
JatinJatin
Jatin
 
Jatin singla
Jatin singlaJatin singla
Jatin singla
 
Jatin
JatinJatin
Jatin
 
Singla
SinglaSingla
Singla
 
Jatin singla
Jatin singlaJatin singla
Jatin singla
 
Jatin singla (2)
Jatin singla (2)Jatin singla (2)
Jatin singla (2)
 
Jatin singla project ppt
Jatin singla project pptJatin singla project ppt
Jatin singla project ppt
 
Jatin industrial ppt
Jatin industrial  pptJatin industrial  ppt
Jatin industrial ppt
 
regulation of herbal products
regulation of herbal productsregulation of herbal products
regulation of herbal products
 
Jatin an overview of sunscreen regulations in the world
Jatin  an overview of sunscreen regulations in the worldJatin  an overview of sunscreen regulations in the world
Jatin an overview of sunscreen regulations in the world
 
Jatin article qbd
Jatin article qbdJatin article qbd
Jatin article qbd
 
Multiple emulsion
Multiple emulsionMultiple emulsion
Multiple emulsion
 
Jatin. biovailability
Jatin. biovailabilityJatin. biovailability
Jatin. biovailability
 
Jatin validation
Jatin validationJatin validation
Jatin validation
 
Jatin ivivc
Jatin ivivcJatin ivivc
Jatin ivivc
 

Dernier

An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
SanaAli374401
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
PECB
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
MateoGardella
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 

Dernier (20)

Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 

Non linear pharmacokinetics.

  • 2. PHARMACOKINETICS The study of absorption, distibution,metabolism,excretio of drug and their relationship to pharmacological response. In simple word ; what the body dose to the drug. Linear pharmacokinetics.In the pharmacokinetic parameter for drug would not change when difference dose or multiple dose of drug is given. Non linear pharmcokinetics-if any deviation cause linear pharmacokinetics called non linear, mixed, capacity – limited kinetics.
  • 3. CAUSES Of NON LINEARITY  Absorption  Saturable transport - riboflavin  Intestinal metabolism - prodrug  Distribution  Plasma protein binding - cefriaxone  CSF transport – benzyl penicillin  Tissue binding - prednisolone  Cellular Uptake - methicillin  Hepatic uptake – indocyanin green
  • 4.  Metabolism  Saturable metabolism – phynetoin  Co-substrate depletion – acetaminophen  plasma protein binding – prednisolone  Elimination  Glomerular filtration -  Tubular secretion – penicilline G  Tubular reabsorption – water soluble vitamin
  • 6. MICHAELIS-MENTEN KINETICS Drug biotransformation ,renal tubular secretion,and biliary secretion usually require enzyme or carrier systems. These systems are relatively specific with respect to substrate and have finite capacities(I.e., they are said to be capacity limited). Frequently, the kinetics of these capacity-limited processes can be described by the Michaelis Menten equation:
  • 7. dc/dt – rate of decline of drug concentration with time . Vmax - theoretical maximum rate of the process. Km – michelis constant C<<Km – under this stiuation ,the equation Km+C =km -dC/dt=Vmax C/ Km C>>Km- under this situation Km+C=C -dC/dt=Vmax
  • 9. ESTIMATION OF Km AND Vmax  The parameter of capacity limited processes like metabolism, renal tubular secretion and excretion can be easily define by assuming one compartment kinetics for the drug and that elimination invovles only a single capacity limited process.  The Km and Vmax can be assessed from the plasma conc .time data collected after i.v bolus administration of drug with non linear elimination.
  • 10.  Rewritting equation – dc/dt =Vmax c/Km+c  Integration followed by conversation to log10 log C=logC0 + (c0 -c)/2.303Km –Vmax / 2.303Km  The Equation describe the line- LogC=logC<- 0 –Vmax /2.303Km
  • 11.
  • 12. At low plasma concentrations are identical. By setting the right-hand sides of these two equations equal to each other, the following expression is obtained.
  • 13. Km AND Vmax FROM STEADY STATE 1) Linear-Burke plot/klotz plot 1/DR= Km/Vmax.Css+1/Vmax 2) The third Graphical method oR Direct Linear Method: DR= Vmax-Km/Css
  • 15. Km and Vmax can also be calculated numerically by setting up simultaneous equation as shown below: DR= V max Css.1/Km+Css.1 DR= V max Css.2/ Km+Css.2 Combination of the above two equation yields: Km= DR2-DR1/(DR.1/Css.1)-(DR.2/Css.2)